All Stories

  1. Interventional electrophysiology in Bulgaria in 2023: data from the electronic registry BG-EPHY
  2. Cardioneuroablation for recurrent vasovagal syncope and functional sinus bradycardia: a case series
  3. Editorial
  4. Double fire tachycardia
  5. Cardioneuroablation for the Treatment of Vasovagal Syncope: Current Status and Impact on Quality of Life
  6. Interventional electrophysiology in bulgaria in 2022: data from the electronic registry BG-EPHY
  7. Myocardial infarction-related ventricular arrhythmias
  8. Proposing national diagnostic reference levels for electrophysiology studies and catheter ablation procedures in Bulgaria
  9. Early catheter ablation for ventricular tachycardia in structural heart disease
  10. Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry
  11. Clinical complexity and impact of the ABC (Atrial fibrillation Better Care) pathway in patients with atrial fibrillation: a report from the ESC-EHRA EURObservational Research Programme in AF General Long-Term Registry
  12. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
  13. Epidemiology and impact of frailty in patients with atrial fibrillation in Europe
  14. Interventional electrophysiology in Bulgaria in 2021: data from the electronic registry BG-EPHY
  15. MRI for diagnosing MINOCA
  16. Protocol for updated systematic review of catheter ablation for ventricular tachycardia
  17. Impact of anthropometric factors on outcomes in atrial fibrillation patients: analysis on 10 220 patients from the European Society of Cardiology (ESC)-European Heart Rhythm Association (EHRA) EurObservational Research Programme on Atrial Fibrillation ...
  18. Cardiac troponins and adverse outcomes in European patients with atrial fibrillation: A report from the ESC-EHRA EORP atrial fibrillation general long-term registry
  19. Left free wall‐sided Mahaim type fiber and A‐V nodal reentry tachycardia: Unusual but not impossible combination
  20. Impact of malignancy on outcomes in European patients with atrial fibrillation: A report from the ESC‐EHRA EURObservational research programme in atrial fibrillation general long‐term registry
  21. Impact of renal impairment on atrial fibrillation: ESC‐EHRA EORP‐AF Long‐Term General Registry
  22. LEFT FREE WALL-SIDED MAHAIM TYPE FIBER AND AV NODAL REENTRY TACHYCARDIA -- UNUSUAL BUT NOT IMPOSSIBLE COMBINATION
  23. Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study
  24. Clinical utility and prognostic implications of the novel 4S-AF scheme to characterize and evaluate patients with atrial fibrillation: a report from ESC-EHRA EORP-AF Long-Term General Registry
  25. Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients: a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry
  26. Anatomic variants of pulmonary venous drainage and their relation to recurrences of atrial fibrillation after pulmonary vein isolation
  27. Catheter ablation of macroreentrant atrial tachycardias following transconduit puncture access in a patient after total cavopulmonary connection with an extracardiac conduit
  28. High-sensitivity cardiac troponin and C-reactive protein dynamics after cardiac electrophysiological procedures
  29. Left atrial thrombosis in patients with atrial fibrillation during uninterrupted oral anticoagulation
  30. Review of interventional electrophysiology in Bulgaria in 2019 and 2020: data from the electronic ablation registry BG-EPHY 
  31. Recurrences of atrial fibrillation after first radiofrequency pulmonary vein isolation in patients with paroxysmal atrial fibrillation: single center follow-up
  32. Distribution and area of low voltage and dense scar zones and their relation to left atrial enlargement in ablation-naïve patients with paroxysmal atrial fibrillation
  33. Relation of outcomes to ABC (Atrial Fibrillation Better Care) pathway adherent care in European patients with atrial fibrillation: an analysis from the ESC-EHRA EORP Atrial Fibrillation General Long-Term (AFGen LT) Registry
  34. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
  35. Catheter ablation of atrial tachycardia via extracardiac access
  36. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: results of the EU-CERT-ICD controlled multicentre cohort study
  37. Catheter Ablation of Idiopathic Ventricular Arrhythmias Originating from the Para-Hisian area - QRS Morphology Change and Late Effect of the Ablation: Case Series
  38. Appropriate Shocks and Mortality in Patients With Versus Without Diabetes With Prophylactic Implantable Cardioverter Defibrillators
  39. Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project
  40. Atrial fibrillation history impact on catheter ablation outcome. Findings from the ESC-EHRA Atrial Fibrillation Ablation Long-Term Registry
  41. OUP accepted manuscript
  42. Rationale and design of the EU-CERT-ICD prospective study: comparative effectiveness of prophylactic ICD implantation
  43. Impact of body mass index on the outcome of catheter ablation of atrial fibrillation
  44. Correlation between the sudden jump-like increases of the atrio-Hisian interval induced during burst atrial pacing and during programmed atrial stimulation in patients with atrioventricular nodal reentrant tachycardia
  45. Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation: a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry
  46. The non-fluoroscopic navigation reduces significantly not only the fluoroscopic exposure during catheter ablation of the cavotricuspid isthmus but the total radiofrequency time as well
  47. 2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS
  48. Evolution of The Electrocardiogram in a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy
  49. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
  50. Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
  51. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
  52. Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)
  53. The presence of extensive atrial scars hinders the differential diagnosis of focal or macroreentrant atrial tachycardias in patients with complex congenital heart disease
  54. Coexistence of arrhythmogenic right ventricular cardiomyopathy and coronary artery disease in a patient with ventricular tachycardia: a highly unusual combination
  55. Inadvertent isolation of a focal tachycardia within the superior vena cava
  56. Poster Session 4
  57. Electrogram analysis at the His bundle region and the proximal coronary sinus as a tool to predict left atrial origin of focal atrial tachycardias
  58. Selective slow pathway ablation using transseptal approach in a patient with surgically corrected partial atrioventricular canal defect and atrioventricular nodal reentrant tachycardia of the common type
  59. Percutaneous Coronary Intervention for Acute Myocardial Infarction in a Single Coronary Artery Anomaly
  60. ABSTRACTS
  61. Featured Posters: An overview of cardiac electrophysiology and pacing
  62. Bi-atrial and right atrial activation times help to differentiate focal from macroreentrant right atrial tachycardias
  63. Acceso transeptal a la aurícula izquierda desde la vena femoral izquierda
  64. Transseptal Access to the Left Atrium From the Left Femoral Vein
  65. Ice mapping during tachycardia in close proximity to the AV node is safe and offers advantages for transcatheter ablation procedures
  66. Mid-term echocardiographic follow up of left ventricular function with permanent right ventricular pacing in pediatric patients with and without structural heart disease
  67. Evolution of left ventricular function in paediatric patients with permanent right ventricular pacing for isolated congenital heart block: a medium term follow-up
  68. A simple algorithm for defining the mechanism and the chamber of origin in atrial tachycardias
  69. Unusual Wenckebach phenomenon due to an atrial tachycardia arising from the apex of Koch’s triangle in the presence of dual AV nodal physiology
  70. Right diaphragmatic paralysis following endocardial cryothermal ablation of inappropriate sinus tachycardia
  71. P4-109
  72. Association for European Paediatric Cardiology, Association Européene pour la Cardiologie Pédiatrique, XL Annual Meeting, 18–21 May, 2005
  73. Evolution of left ventricular function in pediatric patients with permanent right ventricular pacing with and without structural heart disease
  74. Preventing complicated transseptal puncture with intracardiac echocardiography: case report
  75. 685 Ice mapping during tachycardia in close proximity to the AV node is safe and offers advantages for transcatheter ablation procedures
  76. P-086 Short-term and long-term results of radiofrequency catheter ablation for the treatment of tachycardias in children and adolescents
  77. P-086 Short-term and long-term results of radiofrequency catheter ablation for the treatment of tachycardias in children and adolescents
  78. Brief Communications of the International Society of Non-Invasive Cardiology, 19 th European Congress, May 8-10, 2003 - Istanbul, Turkey
  79. ORAL PRESENTATION: ATHIAL FIBRILLATION: PHYSIOLOGICAL AND PATHOPHYSIOLOGICAL FINDINGS